Hanna Leinonen

2.9k total citations · 1 hit paper
23 papers, 2.4k citations indexed

About

Hanna Leinonen is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Hanna Leinonen has authored 23 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Oncology. Recurrent topics in Hanna Leinonen's work include Genomics, phytochemicals, and oxidative stress (12 papers), Virus-based gene therapy research (8 papers) and Glutathione Transferases and Polymorphisms (5 papers). Hanna Leinonen is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (12 papers), Virus-based gene therapy research (8 papers) and Glutathione Transferases and Polymorphisms (5 papers). Hanna Leinonen collaborates with scholars based in Finland, United States and Luxembourg. Hanna Leinonen's co-authors include Anna–Liisa Levonen, Emilia Kansanen, Suvi Linna-Kuosmanen, Seppo Ylä‐Herttuala, Petri Pölönen, Tarja Malm, Henna-Kaisa Jyrkkänen, Katja M. Kanninen, Jari Koıstınaho and Steven R. Woodcock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Hanna Leinonen

23 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer

2013 1.1k citations Emilia Kansanen, Suvi Linna-Kuosmanen et al. Redox Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanna Leinonen Finland	19	1.7k	272	240	213	179	23	2.4k
Daniel P. Stewart United States	16	2.7k 1.6×	211 0.8×	215 0.9×	206 1.0×	164 0.9×	26	3.4k
Durga Nand Tripathi India	27	1.4k 0.8×	257 0.9×	310 1.3×	111 0.5×	115 0.6×	46	2.7k
Keon Wook Kang South Korea	30	1.7k 1.0×	209 0.8×	295 1.2×	130 0.6×	122 0.7×	87	2.7k
Venugopal Radjendirane United States	13	1.9k 1.1×	150 0.6×	192 0.8×	140 0.7×	141 0.8×	16	2.3k
Suhn Hee Kim South Korea	32	1.5k 0.9×	299 1.1×	150 0.6×	145 0.7×	80 0.4×	158	3.1k
Kumuda C. Das United States	28	1.5k 0.9×	319 1.2×	345 1.4×	247 1.2×	69 0.4×	56	2.6k
Konjeti R. Sekhar United States	31	2.2k 1.3×	305 1.1×	274 1.1×	304 1.4×	87 0.5×	65	3.3k
Philip J. Sherratt United Kingdom	14	2.1k 1.2×	176 0.6×	198 0.8×	157 0.7×	85 0.5×	16	2.6k
Gábor Bánhegyi Hungary	35	1.3k 0.8×	382 1.4×	151 0.6×	284 1.3×	146 0.8×	99	3.4k
Soona Shin United States	20	1.6k 0.9×	292 1.1×	219 0.9×	90 0.4×	149 0.8×	27	2.3k

Countries citing papers authored by Hanna Leinonen

Since Specialization

Citations

This map shows the geographic impact of Hanna Leinonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Leinonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Leinonen more than expected).

Fields of papers citing papers by Hanna Leinonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Leinonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Leinonen. The network helps show where Hanna Leinonen may publish in the future.

Co-authorship network of co-authors of Hanna Leinonen

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Leinonen. A scholar is included among the top collaborators of Hanna Leinonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Leinonen. Hanna Leinonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leinonen, Hanna, et al.. (2024). Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing. Cytotherapy. 26(9). 1084–1094. 1 indexed citations

Galibert, Lionel, Hanna Leinonen, Igor Oruetxebarria, et al.. (2022). Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy. Frontiers in Medicine. 9. 1052318–1052318. 10 indexed citations

Leinonen, Hanna. (2022). Commercial-scale lentiviral vector manufacturing: is the myth busted?. Cell and Gene Therapy Insights. 8(1). 3–13. 3 indexed citations

Bowen, Sean, Hanna Leinonen, Hanna P. Lesch, et al.. (2020). Detection of lentiviral suicide gene therapy in C6 rat glioma using hyperpolarised [1‐¹³C]pyruvate. NMR in Biomedicine. 33(4). e4250–e4250. 5 indexed citations

Leinonen, Hanna, et al.. (2020). Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production. Human Gene Therapy. 31(5-6). 376–384. 19 indexed citations

Oruetxebarria, Igor, Hanna Leinonen, Tommi Heikura, et al.. (2020). Development of Large-Scale Downstream Processing for Lentiviral Vectors. Molecular Therapy — Methods & Clinical Development. 17. 717–730. 49 indexed citations

Pölönen, Petri, Ashik Jawahar Deen, Hanna Leinonen, et al.. (2019). Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma. Oncogene. 38(50). 7473–7490. 66 indexed citations

Leinonen, Hanna, Igor Oruetxebarria, Haritha Samaranayake, et al.. (2019). Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells. Molecular Therapy — Methods & Clinical Development. 15. 63–71. 19 indexed citations

Leinonen, Hanna, et al.. (2017). Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor. Gene Therapy. 25(1). 39–46. 62 indexed citations

10.

Linna-Kuosmanen, Suvi, Tuomo Laitinen, Mikael Peräkylä, et al.. (2016). The Effects of Sequence Variation on Genome-wide NRF2 Binding—New Target Genes and Regulatory SNPs. Nucleic Acids Research. 44(4). 1760–1775. 32 indexed citations

11.

Kanninen, Katja M., Yuriy Pomeshchik, Hanna Leinonen, et al.. (2015). Applications of the Keap1–Nrf2 system for gene and cell therapy. Free Radical Biology and Medicine. 88(Pt B). 350–361. 42 indexed citations

12.

Leinonen, Hanna, et al.. (2014). Role of the Keap1–Nrf2 Pathway in Cancer. Advances in cancer research. 122. 281–320. 135 indexed citations

13.

Kansanen, Emilia, Suvi Linna-Kuosmanen, Hanna Leinonen, & Anna–Liisa Levonen. (2013). The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biology. 1(1). 45–49. 1065 indexed citations breakdown →

14.

Leinonen, Hanna, Anna‐Kaisa Ruotsalainen, Ann‐Marie Määttä, et al.. (2012). Oxidative Stress-Regulated Lentiviral TK/GCV Gene Therapy for Lung Cancer Treatment. Cancer Research. 72(23). 6227–6235. 37 indexed citations

15.

Kansanen, Emilia, Gustavo Bonacci, Francisco J. Schöpfer, et al.. (2011). Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism. Journal of Biological Chemistry. 286(16). 14019–14027. 166 indexed citations

16.

Jauhiainen, Suvi, Sanna-Kaisa Häkkinen, Pyry I. Toivanen, et al.. (2011). Vascular Endothelial Growth Factor (VEGF)-D Stimulates VEGF-A, Stanniocalcin-1, and Neuropilin-2 and Has Potent Angiogenic Effects. Arteriosclerosis Thrombosis and Vascular Biology. 31(7). 1617–1624. 35 indexed citations

17.

Kivelä, Annukka M., Petri I. Mäkinen, Henna-Kaisa Jyrkkänen, et al.. (2010). Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells. Atherosclerosis. 213(1). 122–128. 30 indexed citations

18.

Levonen, Anna–Liisa, et al.. (2010). Cytochrome P450 2A5 Constitutive Expression and Induction by Heavy Metals Is Dependent on Redox-Sensitive Transcription Factor Nrf2 in Liver. Chemical Research in Toxicology. 23(5). 977–985. 41 indexed citations

19.

Kansanen, Emilia, Henna-Kaisa Jyrkkänen, Oscar L. Volger, et al.. (2009). Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells. Journal of Biological Chemistry. 284(48). 33233–33241. 141 indexed citations

20.

Kanninen, Katja M., Riikka Heikkinen, Tarja Malm, et al.. (2009). Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences. 106(38). 16505–16510. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact